San Diego, CA -- (SBWire) -- 11/09/2021 --Tenax Therapeutics, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Tenax Therapeutics, Inc. (NASDAQ: TENX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether certain statements by Tenax Therapeutics, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Morrisville, NC based Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. Tenax Therapeutics, Inc. reported that its Net Loss increased from $8.39 million in 2019 to $9.85 million in 2020.
Shares of Tenax Therapeutics, Inc. (NASDAQ: TENX) declined from $3.04 per share in February 2021 to as low as $1.23 per share in September 2021.
On November 8, 2021, NASDAQ: TENX shares closed at $1.54 per share.
Those who purchased shares of Tenax Therapeutics, Inc. (NASDAQ: TENX) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
NASDAQ:TENX Investor Notice: Investigation over Possible Securities Laws Violations by Tenax Therapeutics, Inc.
An investigation for investors in Tenax Therapeutics, Inc. (NASDAQ:TENX) shares over potential securities laws violations by Tenax Therapeutics, Inc. was announced.